Literature DB >> 1744647

The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.

D F Smith1, J L Hutton, D Sandemann, P M Foy, M D Shaw, I R Williams, D W Chadwick.   

Abstract

It is not known whether conservative or early aggressive (resective surgery with or without radiotherapy) management is better for tumours presenting with epilepsy. The prognosis of 560 patients with a clinical and CT diagnosis of intrinsic supratentorial tumour was examined retrospectively. Epilepsy was the first symptom in 164 patients. Histological confirmation of diagnosis was available in 391 (70%) of cases. Median survival was 37 months in the group presenting with epilepsy and six months in those presenting with other symptoms (p less than 0.0001). Patients presenting with epilepsy were more likely to have a normal clinical examination, a non-enhancing low density lesion on CT scan and a low grade tumour. From Cox's stepwise proportional hazards model, significant independent variables adversely affecting prognosis were increasing age, focal neurological signs and enhancing CT lesions at diagnosis, non-resective surgery and male sex. Of those presenting with epilepsy 80 patients had surgical treatment within two months of CT diagnosis. The Cox's model failed to identify any beneficial effects for either early resective surgery or radiotherapy. In primary intracerebral tumours with presentations other than epilepsy, resective surgery and radiotherapy were amongst the important factors associated with prolonged survival. Primary intracerebral tumours presenting with epilepsy are relatively benign and their outcome appears to be chiefly determined by clinical factors.

Entities:  

Mesh:

Year:  1991        PMID: 1744647      PMCID: PMC1014578          DOI: 10.1136/jnnp.54.10.915

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

Authors:  M J Winger; D R Macdonald; J G Cairncross
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

2.  TREATMENT OF MALIGNANT GLIOMATA.

Authors:  E HITCHCOCK; R SATO
Journal:  J Neurosurg       Date:  1964-06       Impact factor: 5.115

3.  Glioblastoma multiforme: a clinical survey.

Authors:  J G ROTH; A R ELVIDGE
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

4.  Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment.

Authors:  S A FRANKEL; W J GERMAN
Journal:  J Neurosurg       Date:  1958-09       Impact factor: 5.115

5.  Reoperation in the treatment of recurrent intracranial malignant gliomas.

Authors:  M Ammirati; J H Galicich; E Arbit; Y Liao
Journal:  Neurosurgery       Date:  1987-11       Impact factor: 4.654

6.  Experience in 300 cases of CT-directed stereotactic surgery for lesion biopsy and aspiration of haematoma.

Authors:  D G Thomas; R M Nouby
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

7.  The management of patients with an intrinsic supratentorial brain tumour.

Authors:  D R Sandeman; A P Sandeman; P Buxton; H H Hughes; D W Chadwick; I R Williams; R D Baker; P M Foy; D M Shaw
Journal:  Br J Neurosurg       Date:  1990       Impact factor: 1.596

8.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

Authors:  P C Burger; S B Green
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860

9.  Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy?

Authors:  M S Choksey; A Valentine; H Shawdon; C E Freer; K W Lindsay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

10.  Selection bias in clinical trials of anaplastic glioma.

Authors:  M J Winger; D R Macdonald; S C Schold; J G Cairncross
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

View more
  18 in total

1.  The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.

Authors:  J N Wilden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma.

Authors:  K Lote; T Egeland; B Hager; K Skullerud; H Hirschberg
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

3.  Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.

Authors:  M L van Veelen; C J Avezaat; J M Kros; W van Putten; C Vecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

4.  Development of prognostic index for primary supratentorial intracerebral tumours.

Authors:  J L Hutton; D F Smith; D Sandemann; P M Foy; M D Shaw; I R Williams; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

5.  Morphological characteristics of brain tumors causing seizures.

Authors:  Jong Woo Lee; Patrick Y Wen; Shelley Hurwitz; Peter Black; Santosh Kesari; Jan Drappatz; Alexandra J Golby; William M Wells; Simon K Warfield; Ron Kikinis; Edward B Bromfield
Journal:  Arch Neurol       Date:  2010-03

6.  Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity.

Authors:  J C Bartolomei; S Christopher; K Vives; D D Spencer; J M Piepmeier
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

7.  Seizures in patients with supratentorial oligodendroglial tumours. Clinicopathological features and management considerations.

Authors:  I R Whittle; A Beaumont
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 8.  The role of surgery in low grade gliomas.

Authors:  J Bampoe; M Bernstein
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 9.  Effect of age on treatment decisions in low-grade glioma.

Authors:  C J Vecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

10.  Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.

Authors:  J Vesper; E Graf; C Wille; J Tilgner; M Trippel; G Nikkhah; Cb Ostertag
Journal:  BMC Neurol       Date:  2009-07-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.